CA1051776A - Gel de poloxamer-iode - Google Patents
Gel de poloxamer-iodeInfo
- Publication number
- CA1051776A CA1051776A CA232,731A CA232731A CA1051776A CA 1051776 A CA1051776 A CA 1051776A CA 232731 A CA232731 A CA 232731A CA 1051776 A CA1051776 A CA 1051776A
- Authority
- CA
- Canada
- Prior art keywords
- iodine
- gel
- poloxamer
- weight
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- UYKWDAPDQOLFRV-UHFFFAOYSA-N 2-methyloxirane;molecular iodine;oxirane Chemical compound II.C1CO1.CC1CO1 UYKWDAPDQOLFRV-UHFFFAOYSA-N 0.000 title claims abstract 9
- 239000000203 mixture Substances 0.000 claims abstract description 29
- 229920000642 polymer Polymers 0.000 claims abstract description 23
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims abstract description 9
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000006172 buffering agent Substances 0.000 claims abstract description 5
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 16
- 239000011630 iodine Substances 0.000 claims description 16
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 3
- 229940006461 iodide ion Drugs 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 239000012736 aqueous medium Substances 0.000 claims 1
- 125000000963 oxybis(methylene) group Chemical group [H]C([H])(*)OC([H])([H])* 0.000 claims 1
- 229920001451 polypropylene glycol Polymers 0.000 abstract description 5
- 230000002070 germicidal effect Effects 0.000 abstract description 4
- -1 polyoxypropylene Polymers 0.000 abstract description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract description 2
- PWIDFFRKCKLPNI-UHFFFAOYSA-M [I+].[I-] Chemical compound [I+].[I-] PWIDFFRKCKLPNI-UHFFFAOYSA-M 0.000 abstract description 2
- 230000000699 topical effect Effects 0.000 abstract description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 40
- 229920001983 poloxamer Polymers 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 229920001992 poloxamer 407 Polymers 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000536 complexating effect Effects 0.000 description 2
- 239000008139 complexing agent Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 241000736839 Chara Species 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- 101100126167 Escherichia coli (strain K12) intD gene Proteins 0.000 description 1
- 101100021923 Helicobacter pylori (strain ATCC 700392 / 26695) lspA gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101100536883 Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) thi5 gene Proteins 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 101100240664 Schizosaccharomyces pombe (strain 972 / ATCC 24843) nmt1 gene Proteins 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- NNYBQONXHNTVIJ-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=C1C(C=CC=C1CC)=C1N2 NNYBQONXHNTVIJ-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 229940063718 lodine Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 101150070667 ureD gene Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49603574A | 1974-08-09 | 1974-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1051776A true CA1051776A (fr) | 1979-04-03 |
Family
ID=23970988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA232,731A Expired CA1051776A (fr) | 1974-08-09 | 1975-08-01 | Gel de poloxamer-iode |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA1051776A (fr) |
| GB (1) | GB1516653A (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4215116A (en) * | 1978-06-30 | 1980-07-29 | Block Drug Company Inc. | Propoxylate toxicants |
| WO1981000207A1 (fr) * | 1979-07-11 | 1981-02-05 | P Harrigan | Preparation pharmaceutique - agent local de sterilisation des mains |
| DE3131112A1 (de) * | 1981-08-06 | 1983-02-24 | Braun Melsungen Ag | Antimikrobielle zubereitungen zur behandlung naessender offener wunden |
| DE3428264A1 (de) * | 1984-07-27 | 1986-03-06 | Schering Ag | Gelhaltige pharmazeutische zubereitungen |
| US4851217A (en) * | 1987-05-05 | 1989-07-25 | Basf Corporation | All aqueous formulations of organo-phosphorous pesticides |
| MX9305535A (es) * | 1992-09-18 | 1994-03-31 | West Agro Inc | Composiciones y concentrados germicidas a base de yodo-detergente, acuosos y estables. |
| GB2281697A (en) * | 1993-09-14 | 1995-03-15 | Euro Celtique Sa | Laxative compositions in capsules |
| EP3897134B1 (fr) * | 2018-12-14 | 2025-01-08 | Ecolab USA Inc. | Compositions antimicrobiennes stables contenant de l'iode pour trempage de trayons |
-
1975
- 1975-08-01 CA CA232,731A patent/CA1051776A/fr not_active Expired
- 1975-08-07 GB GB32983/75A patent/GB1516653A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1516653A (en) | 1978-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0088394B1 (fr) | Composition stable effervescente pour suppositoire vaginal et suppositoires fabriqués à l'aide de cette composition | |
| US3969280A (en) | Solid air freshener gels | |
| CA1051776A (fr) | Gel de poloxamer-iode | |
| US2550622A (en) | Ointment base and iodine ointment | |
| JPH08500364A (ja) | 減少した洗剤含量を有する殺菌性洗剤−ヨウ素組成物 | |
| GB2288186A (en) | Toilet cleansing gel block | |
| US4178264A (en) | Air treating gel composition | |
| FI66904B (fi) | Viskos flytande tvaolkomposition | |
| EP0797620B1 (fr) | Procede de preparation d'une suspension d'ether cellulosique dans de l'eau et melange sec convenant a la preparation de ladite suspension | |
| JP2556332B2 (ja) | 透明ゲル状組成物 | |
| US4755378A (en) | Iodophor-containing suppository | |
| US4390451A (en) | Concentrated aqueous metal aldonate and/or ammonium aldonate composition | |
| SE510135C2 (sv) | Vattenhaltig suspension av en cellulosaeter, sätt för dess framställning samt komposition | |
| HU196902B (en) | Process for production of locally applicable medical compositions helping wound-granulation and formation of pellicle | |
| JPS59131684A (ja) | ゲル組成物およびその環境温度における製造方法 | |
| JP2769707B2 (ja) | 透明水性ゲル状芳香剤組成物 | |
| JP3981448B2 (ja) | 新規なカルボキシメチルセルロースナトリウム塩含有水性ゲル組成物及びその製造法 | |
| JPH0725735A (ja) | 含嗽剤 | |
| JPH02205A (ja) | 香料含有ソフトカプセル用コーティング剤 | |
| JP2003119129A (ja) | 塩化ベンザルコニウム含有ゲル状外用剤 | |
| JP2001276203A (ja) | ゲル状芳香剤組成物 | |
| US3159539A (en) | Water-soluble antiseptic agent | |
| CN110037050A (zh) | 一种高效复合碘溶液及其制备方法 | |
| JPWO2000029026A1 (ja) | 坐 剤 | |
| JPH11315035A (ja) | 軟膏製剤 |